Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies (Tables)

v3.22.1
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Schedule of condensed balance sheet are reconciled
Gross proceeds   $ 172,500,000  
Less:        
Proceeds allocated to Public Warrants     (6,037,500 )
Proceeds allocated to Public Rights     (3,934,879 )
Issuance costs allocated to common stock     (3,672,335 )
Plus:        
Accretion of carrying value to redemption value     15,369,714  
Common stock subject to possible redemption   $ 174,225,000  

 
Schedule of basic and diluted net income (loss) per common share
    Three Months Ended September 30,
2021		     Nine Months Ended September 30,
2021		     Three Months Ended September 30,
2020		     For the period from June 18, 2020 (inception) through September 30,
2020		  
Basic and diluted net loss per share:                        
Numerator:                        
Net loss   $ (4,438,654 )   $ (4,438,654 )   $
—
     $ (1,000 )
Denominator                                
Basic weighted average shares outstanding     17,760,989      

8,437,500

       3,750,000       3,750,000  
Basic net loss per share of common stock (as restated)   $ (0.25 )   $ (0.53 )   $ 0.00     $ (0.00 )